Thus, inhibition of the enzymes involved in the biodegradation of the endocannabinoids has been shown to play a role in cancer cell viability, migration, and metastasis, as, for instance, does the FAAH inhibitor URB597 (Table 1) in lung cancer cells (Winkler et al., 2016). This evidence concerns the gene FAAH and cancer.